Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat intramyocardial autologous bone marrow cell injection for residual refractory angina
2009-017924-18Phase 3Completed
- Start
- Jun 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of autologous bone marrow-derived mononuclear cell in angina pectoris, coronary arteriosclerosis and cardiac ischemia. Primary endpoint: Efficacy. Started Jun 2010; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
angina pectoriscoronary arteriosclerosiscardiac ischemia
Beyond the preview
Go deeper on 2009-017924-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017924-18.